DP
ACLX

Diadema Partners’s Arcellx ACLX Stock Holding History

Diadema Partners’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,100
Closed -$775K – 105
2024
Q4 		$775K Buy
+10,100
New +$873K 0.33% 62

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Diadema Partners's ACLX Position: Q1 2025 in Review

Diadema Partners sold out of Arcellx (ACLX) in Q1 2025, closing a stake of 10,100 shares — an estimated $775K sold.

Diadema Partners first reported a position in ACLX in Q4 2024 and held it in 1 quarter. The position peaked at $775K in Q4 2024. 197 funds tracked by Wall St. Rank hold ACLX as of Q1 2025.

  • Diadema Partners reported no remaining Arcellx position as of Q1 2025 after selling out during the quarter.
  • Diadema Partners sold 10,100 Arcellx shares in Q1 2025, an estimated $775K.
  • Diadema Partners first reported a position in Arcellx in Q4 2024 and held it in 1 quarter.
  • Diadema Partners's Arcellx position peaked at $775K in Q4 2024.
  • 197 funds tracked by Wall St. Rank held Arcellx as of Q1 2025.

Based on Diadema Partners's 13F filing for Q1 2025, filed 15 May 2025.